obesity drug news today glp-1 2025 oct 27 More news: in a late-stage study in type 2 diabetes and elevated cardiovascular risk, our new GLP-1 pill showed cardiovascular safety. Read more: https://e.lilly/4myJlm8 Pentagon Drops Coverage of GLP-1

Although predominantly found in the gastrointestinal and neural tracts, GLP-1R is also present in other tissues, including kidney, skeletal and smooth muscle, liver and adipose [39]

There are currently 13 clinical trials investigating GLP-1RAs for PCOS registered with a National Clinical Trial number, targeting various outcomes of GLP-1RAs on PCOS patients, including weight loss, hormonal changes, metabolic health, and reproductive parameters

E., Dennis, M

A 2025 Consumer Reports survey found 34% of GLP-1 patients hit unexpected charges, and this is where most of them came from

Tobacco Use Disorder Outcomes Wang, Volkow, and colleagues also conducted a study of 222,942 individuals with tobacco use disorder and type 2 diabetes, with findings showing individuals prescribed semaglutide showed a 32% lower risk of tobacco-related healthcare visits and were less likely to need smoking cessation medications or counseling during the 12-month follow-up period, with the most notable effects appearing within the first 30 days (Wang et al., 2024c)

Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value